Category: TRIALOMICS

July 9, 2021 0

Virtual clinical trials in vogue

By FM

Virtual/digital clinical trials – performed by partly or entirely avoiding patient visits to clinical trial sites – have become the new flavour of the season in the post-pandemic setting.

March 6, 2021 0

Societal interest vs individual rights

By FM

Post-trial access (PTA) of an investigational new product is an ethical right of the clinical trial participants. Usually, the option of PTA is available to the participants after the clinical trial is completed.

February 6, 2021 0

Post-vaccination antibodies and efficacy

By FM

Clinical development of vaccines to counteract SARS-CoV-2 infection assumes that neutralizing antibodies (NAbs) directed at the spike protein will provide protection against the disease.

January 5, 2021 0

Trials and tribulations of assessing safety

By FM

The assessment and monitoring of safety during clinical trials is a vital component of developing COVID-19 vaccines. Expected local and systemic adverse reactions (AR), which characterize the reactogenicity of vaccines, are common.